Biosafety Blog Image

Emphasis on Biosafety in Trials on the Rise

U.S. Food and Drug Administration–approved gene therapies have long been an elusive goal for medical science. However, “the climate is right for advances in clinical trials involving human gene transfer, particularly for oncology research,” says Daniel Eisenman, PhD, RBP, SM(NRCM), CBSP, Biosafety Officer at Schulman IRB. Such clinical trials involve the deliberate transfer of engineered […]